216.12
-1.58
(-0.73%)
At close: April 16 at 1:59:40 PM CST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 3 | 7 | 7 |
| Avg. Estimate | 3.18B | 3.42B | 14.46B | 18.6B |
| Low Estimate | 2.76B | 3.22B | 13.43B | 16.58B |
| High Estimate | 3.47B | 3.67B | 15.49B | 20.68B |
| Year Ago Sales | 2.74B | 2.85B | 11.52B | 14.46B |
| Sales Growth (year/est) | 16.35% | 19.89% | 25.54% | 28.64% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| NUN.MX | -- | -- | -- | -- |
| S&P 500 | 7.04% | 5.20% | 8.89% | 14.14% |
Upgrades & Downgrades
| Upgrade | JP Morgan: Neutral to Overweight | 4/8/2025 |
| Maintains | Barclays: Overweight to Overweight | 2/24/2025 |
| Maintains | JP Morgan: Neutral to Neutral | 2/24/2025 |
| Maintains | UBS: Neutral to Neutral | 2/18/2025 |
| Downgrade | Citigroup: Neutral to Sell | 12/2/2024 |
| Maintains | Goldman Sachs: Buy to Buy | 11/14/2024 |